ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma.
Saved in:
| Title: | ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma. |
|---|---|
| Authors: | Gartrell, Jessica1 (AUTHOR) jessica.gartrell@stjude.org, Navid, Fariba2 (AUTHOR), Yuan, Xiaomeng3 (AUTHOR), Ness, Kirsten K.4 (AUTHOR), Dubrovin, Mikhail5 (AUTHOR), Wang, Fang3,6 (AUTHOR), Pan, Haitao3,7 (AUTHOR), McCarville, Mary Beth6,8 (AUTHOR), Shulkin, Barry L.6,9 (AUTHOR), Helmig, Sara1,10 (AUTHOR), Krasin, Matthew J.1,7 (AUTHOR), Neel, Michael D.2,8 (AUTHOR), Davidoff, Andrew M.3,8 (AUTHOR), Mandrell, Belinda N.4,9 (AUTHOR), Levine, Deena R.1,5 (AUTHOR), Cai, Zhongheng3,6 (AUTHOR), Bishop, Michael W.7,10 (AUTHOR), Pappo, Alberto S.1,8 (AUTHOR), Federico, Sara M.1,9 (AUTHOR) |
| Source: | Cancers. Sep2025, Vol. 17 Issue 17, p2894. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers17172894 |
